Cargando…
BRAF p.V600E genetic testing based on ultrasound-guided fine-needle biopsy improves the malignancy rate in thyroid surgery: our single-center experience in the past 10 years
PURPOSE: Ultrasound-guided fine-needle aspiration biopsy (UG-FNAB) was implemented in Qilu Hospital of Shandong University in 2015 as a preoperative diagnostic method for thyroid surgery. BRAF p.V600E genetic testing was implemented in 2019. This study evaluated the impact of these two tests on the...
Autores principales: | Gong, Lei, Liu, Yan, Guo, Xinghong, Wang, Chuan, Yan, Fei, Liu, Jinbo, Hou, Xinguo, Chen, Li, Liang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450831/ https://www.ncbi.nlm.nih.gov/pubmed/36070149 http://dx.doi.org/10.1007/s00432-022-04235-3 |
Ejemplares similares
-
BRAF(V600E) genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
por: Lu, Yiran, et al.
Publicado: (2023) -
Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies
por: Zhang, Bingfei, et al.
Publicado: (2014) -
Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma
por: Zhang, Xiaojun, et al.
Publicado: (2021) -
Proper Indication of BRAF(V600E) Mutation Testing in Fine-Needle Aspirates of Thyroid Nodules
por: Koh, Jieun, et al.
Publicado: (2013) -
BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules
por: Sheng, Danli, et al.
Publicado: (2021)